Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA)

Historical Holders from Q1 2021 to Q3 2025

Symbol
SANA on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
266,434,249
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
163,623,611
Holdings value
$580,877,242
% of all portfolios
0.002%
Number of holders
177
Number of buys
110
Number of sells
-56
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund IX, L.P. 17.3% $163,630,594 46,093,125 Robert Nelsen 30 Sep 2025
BlackRock, Inc. 4.9% $19,518,125 11,027,189 BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 4.81% $19,023,535 10,747,760 The Vanguard Group 31 Dec 2024

Institutional Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 163,623,611 $580,877,242 +$66,214,912 $3.55 177
2025 Q2 145,417,350 $397,022,759 -$12,602,331 $2.73 152
2025 Q1 149,116,670 $250,510,959 -$14,520,086 $1.68 156
2024 Q4 157,928,176 $257,417,788 -$2,121,232 $1.63 159
2024 Q3 153,260,123 $637,634,346 +$16,640,858 $4.16 150
2024 Q2 148,167,660 $809,021,070 +$44,986 $5.46 144
2024 Q1 146,274,865 $1,462,752,586 +$233,741,262 $10 151
2023 Q4 124,526,898 $508,113,977 -$12,215,240 $4.08 128
2023 Q3 127,513,989 $493,495,510 -$30,211,194 $3.87 132
2023 Q2 134,904,538 $804,023,148 +$26,527,612 $5.96 121
2023 Q1 130,716,654 $427,414,965 +$6,519,444 $3.27 118
2022 Q4 128,403,041 $507,152,945 -$769,516 $3.95 119
2022 Q3 128,339,963 $769,886,255 +$13,983,486 $6 122
2022 Q2 125,590,881 $807,500,039 +$40,235,857 $6.43 111
2022 Q1 119,405,403 $985,831,531 +$36,653,787 $8.26 109
2021 Q4 111,562,858 $1,727,117,718 +$20,231,159 $15.48 101
2021 Q3 75,725,736 $1,706,389,522 +$266,392,448 $22.52 85
2021 Q2 64,059,346 $1,259,281,145 +$104,914,051 $19.66 78
2021 Q1 58,277,829 $1,950,553,711 +$1,950,553,686 $33.47 74